Compare TFIN & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TFIN | OMCL |
|---|---|---|
| Founded | 1981 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Computer Manufacturing |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2000 |
| Metric | TFIN | OMCL |
|---|---|---|
| Price | $61.99 | $42.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $66.20 | $55.83 |
| AVG Volume (30 Days) | 260.7K | ★ 595.8K |
| Earning Date | 04-21-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $7.27 | $6.77 |
| Revenue Next Year | $11.31 | $5.22 |
| P/E Ratio | ★ $66.31 | $174.56 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $46.43 | $26.85 |
| 52 Week High | $77.84 | $51.84 |
| Indicator | TFIN | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 58.80 |
| Support Level | $53.88 | $32.20 |
| Resistance Level | $61.89 | $44.31 |
| Average True Range (ATR) | 2.17 | 1.99 |
| MACD | -0.79 | -0.03 |
| Stochastic Oscillator | 13.11 | 32.55 |
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.